CRT 2016 Collisions – Good Ones

A surgeon, a product director and a preclinical study director bump into each other at the Omni Shoreham lobby… Well, not exactly, but that’s the way the annual CRT conference feels. Like a well designed meeting hub, the event generates “productive collisions” that foster innovation and learning throughout the cardiovascular research technologies ecosystem. Why we…

Preclinical Trials Generate Critical Improvements to St. Jude Medical’s CardioMEMS HF System

“Our experience with T3 Labs for the CardioMEMS device created new knowledge and refinements to the device that resulted in a product that was highly mature at the time we started our clinical trials in humans.” Jason White, St. Jude Medical senior director of product development.

Hemolung RAS Nearer FDA Approval Through Preclinical Research at T3 Labs

ALung Technologies continues to rely on T3 Labs for preclinical research for the Hemolung RAS (Respiratory Assist System) as GLP study for FDA IDE application draws near. ALung’s relationship with T3 began in 2013 for preclinical studies supporting U.S. regulatory approval for the first fully-integrated respiratory dialysis system, Hemolung RAS. Early in the engagement, T3…

Preclinical Case Study: St. Jude Medical & T3 Labs for CardioMEMS HF System

  “At the preclinical stage of medical device product development, there is an important opportunity to identify and implement significant improvements before first clinical use. T3 Labs provides extensive expertise and capabilities in the critical preclinical stage of medical device product development.” – Jason White, Senior Director of Product Development, St. Jude Medical The challenge:…

Case Study: Selecting a New Preclinical Trials Partner – T3 Labs & ALung’s Hemolung RAS in a Calf Model

ALung Technologies needed a CRO with great flexibility and responsiveness in order to maximize limited resources and accelerate the timeline associated with preclinical trials. “T3’s recommendation has accelerated our product refinement testing and preclinical trials saving ALung time and money at every step along the way.” – Jeremy Kimmel, PhD Director of New Technology for ALung Technologies…

The Latest In Preclinical: T3 Labs’ Q4 2015 Quarterly Snapshot

The past few months at T3 Labs have been immensely productive. Along with our preclinical sponsors we continue to produce ground-breaking data. Our sponsors continue to receive regulatory approvals maximizing their investment in preclinical. And our medical device training program continues to ensure physicians and surgeons develop the skills required to fully realize the value…